GHS-R1a signaling drives anxiety-related behavior by shaping excitability of ventromedial hypothalamic neurons
Meng Zhang,
Liu Yang,
Xue Mi,
Gonghui Hu,
Yingchang Lu,
Chen Wang,
Jie Yang,
Xiaomin Sun,
Minglu Niu,
Xianchao Li,
Sihan Wang,
Jingsai Zhang,
Hanbing Yu,
Yuyang Wang,
Ming Yu,
Nan Li and
Yu Zhou ()
Additional contact information
Meng Zhang: University of Health and Rehabilitation Sciences
Liu Yang: Qingdao University
Xue Mi: Qingdao University
Gonghui Hu: Qingdao University
Yingchang Lu: Qingdao University
Chen Wang: Qingdao University
Jie Yang: Qingdao University
Xiaomin Sun: Qingdao University
Minglu Niu: Qingdao University
Xianchao Li: Qingdao University
Sihan Wang: Qingdao University
Jingsai Zhang: Qingdao University
Hanbing Yu: Qingdao University
Yuyang Wang: Affiliated Hospital of Qingdao University
Ming Yu: University of Health and Rehabilitation Sciences
Nan Li: University of Health and Rehabilitation Sciences
Yu Zhou: University of Health and Rehabilitation Sciences
Nature Communications, 2025, vol. 16, issue 1, 1-16
Abstract:
Abstract The neural substrates of anxiety are poorly understood, which hinders treatment of anxiety disorders. Here we found, αCaMKII+ neurons in the ventral medial hypothalamic nucleus (VMH) responded to stressors with increased activity in male mice, both under physiological conditions and after repeated restraint stress. Activation of VMH αCaMKII+ neurons were necessary and sufficient to ameliorate stress-induced anxiety. The peripheral metabolic hormone ghrelin and receptor GHS-R1a play a complex role in emotion regulation; however, the mechanism is uncertain. A delayed increase in GHS-R1a expression in VMH αCaMKII+ neurons coincided with the development of stress-induced enhancement of anxiety-related behavior. GHS-R1a expression in VMH αCaMKII+ neurons promoted anxiety-related behavior, whereas GHS-R1a knockdown had the opposite effect. GHS-R1a upregulation inhibited the excitability of VMH αCaMKII+ neurons. We conclude that GHSR1a signaling drives stress-induced anxiety by shaping the activity of VMH αCaMKII+ neurons. GHS-R1a may be a therapeutic target for treating anxiety disorders such as post-traumatic stress disorder.
Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-59116-3 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59116-3
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-59116-3
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().